OFFICIAL LEGAL TITLE
Prescription Drug Monitoring Act of 2024
FREQUENTLY ASKED QUESTIONS
What is the official ID of this bill?
The official print number for this legislation is 118_S_5563.
Which chamber initiated this legislation?
This legislation was initiated in the Senate.
When did the legislative process begin?
The process officially started on 2024-12-17.
What are the main provisions?
Key points include:
- Practitioners must check the patient's prescription history in the state PDMP before starting treatment with controlled substances and every three months thereafter.
- Pharmacies must electronically report the dispensing of controlled substances to the PDMP within 24 hours, ensuring data is nearly real-time.
- States must ensure their PDMP data is interoperable and shared with other states to prevent cross-state drug abuse.
- State agencies will analyze PDMP data and provide access to law enforcement and medical licensing boards if prescribing patterns appear inconsistent with best practices.
What is the specific legal status?
The current status is Expired.
Where can I read the full text of this legislation?
The full official text is available at:
View full text
Who is the primary sponsor?
The primary sponsor is Sen. Klobuchar, Amy [D-MN].
What is the latest detailed status?
The latest detailed status is: Introduced in Senate
Is this summary verified?
Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.
What is the impact of this bill?
We don't know—that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.